Matrix Metalloproteinase-9 and Myeloperoxidase Expression: Quantitative Analysis by Antigen Immunohistochemistry in a Model of Transient Focal Cerebral Ischemia

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Stroke

• Publication date

  2004-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.STR.0000125861.55804.f2PMID 15060315
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cellular Antioxidant Defense Mechanisms

  2019cited by this paper
• Closure of the Blood-Brain Barrier by Matrix Metalloproteinase Inhibition Reduces rtPA-Mediated Mortality in Cerebral Ischemia With Delayed Reperfusion

  2003cited by this paper
• Matrix metalloproteinases in neuroinflammation

  2002cited by this paper
• Book Review: Role of Superoxide Dismutases in Oxidative Damage and Neurodegenerative Disorders

  2002cited by this paper
• Role of superoxide dismutases in oxidative damage and neurodegenerative disorders.

  2002cited by this paper
• Involvement of Matrix Metalloproteinase in Thrombolysis-Associated Hemorrhagic Transformation After Embolic Focal Ischemia in Rats

  2002cited by this paper
• Inflammatory Response and Glutathione Peroxidase in a Model of Stroke1

  2002cited by this paper
• Expression and activation of matrix metalloproteinase-2 and -9 in rat brain after transient focal cerebral ischemia.

  2001cited by this paper
• Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures.

  2001cited by this paper
• Matrix Metalloproteinase Inhibition Prevents Oxidative Stress-Associated Blood–Brain Barrier Disruption after Transient Focal Cerebral Ischemia

  2001cited by this paper
• Gelatinase B functions as regulator and effector in leukocyte biology

  2001cited by this paper
• Metalloproteinase Inhibition Reduces Thrombolytic (Tissue Plasminogen Activator)–Induced Hemorrhage After Thromboembolic Stroke

  2000cited by this paper
• Inflammatory Mediators of Cerebral Endothelium: A Role in Ischemic Brain Inflammation

  2000cited by this paper
• Role of endothelial nitric oxide generation and peroxynitrite formation in reperfusion injury after focal cerebral ischemia.

  2000cited by this paper
• Interactions of oxidants with vascular signaling systems.

  2000cited by this paper
• Matrix Metalloproteinases Increase Very Early during Experimental Focal Cerebral Ischemia

  1999cited by this paper
• Early Appearance of Activated Matrix Metalloproteinase-9 after Focal Cerebral Ischemia in Mice: A Possible Role in Blood—Brain Barrier Dysfunction

  1999cited by this paper
• Ischemia‐Reperfusion: Mechanisms of Microvascular Dysfunction and the Influence of Risk Factors for Cardiovascular Disease

  1999cited by this paper
• Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain.

  1998cited by this paper
• Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size.

  1998cited by this paper
• Induction of matrix metalloproteinases following brain injury in rats.

  1997cited by this paper
• Role of oxidants in ischemic brain damage.

  1996cited by this paper
• Activated forms of MMP2 and MMP9 in abdominal aortic aneurysms.

  1996cited by this paper
• Extracellular Matrix‐Degrading Proteinases in the Nervous System

  1994cited by this paper
• Brain injury, edema, and vascular permeability changes induced by oxygen‐derived free radicals

  1984cited by this paper

• Blood-Brain Barrier Permeability and Kinetics of Inflammatory Markers in Acute Stroke Patients Treated With Thrombectomy

  2023cites this paper
• Astrocytic NDRG2-PPM1A interaction exacerbates blood-brain barrier disruption after subarachnoid hemorrhage

  2022cites this paper
• Plasma myeloperoxidase levels in acute brain ischaemia and high grade carotid stenosis

  2020cites this paper
• Pathophysiology of Blood–Brain Barrier Permeability Throughout the Different Stages of Ischemic Stroke and Its Implication on Hemorrhagic Transformation and Recovery

  2020cites this paper
• Analysis of the association of MPO and MMP-9 with stroke severity and outcome

  2020cites this paper
• Platelet-to-neutrophil ratio is a prognostic marker for 90-days outcome in acute ischemic stroke.

  2019cites this paper
• Microcirculatory Changes in Experimental Models of Stroke and CNS-Injury Induced Immunodepression

  2019cites this paper
• Dysfunction of Cerebrovascular Endothelial Cells: Prelude to Vascular Dementia

  2018cites this paper
• Multimodal Molecular Imaging Demonstrates Myeloperoxidase Regulation of Matrix Metalloproteinase Activity in Neuroinflammation

  2018cites this paper
• An MRI Hyperintense Acute Reperfusion Marker Is Related to Elevated Peripheral Monocyte Count in Acute Ischemic Stroke

  2018cites this paper
• Mitochondrial Dysfunction in Ischemic Stroke

  2017cites this paper
• Pharmacological Management Options to Prevent and Reduce Ischemic Hemorrhagic Transformation.

  2017cites this paper
• High-dosage granulocyte colony stimulating factor treatment alters monocyte trafficking to the brain after experimental stroke.

  2017cites this paper
• Association of Matrix Metalloproteinases with CVD: Functional Aspects

  2017cites this paper
• Implications of MMP9 for Blood Brain Barrier Disruption and Hemorrhagic Transformation Following Ischemic Stroke

  2016influential citation
• Quantitative Proteomic Analysis of Differentially Expressed Proteins and Downstream Signaling Pathways in Chronic Bladder Ischemia.

  2016cites this paper
• Pathologic factors of brain edema in acute ischemic stroke research

  2015cites this paper
• Treatment with recombinant tissue plasminogen activator (r-TPA) induces neutrophil degranulation in vitro via defined pathways.

  2015cites this paper
• Histamine induces the production of matrix metalloproteinase-9 in human astrocytic cultures via H1-receptor subtype

  2015cites this paper
• The rapid lipopolysaccharide‐induced release of matrix metalloproteinases 9 is suppressed by simvastatin

  2015cites this paper
• Matrix Metalloproteinase in Blood-Brain Barrier Breakdown in Dementia

  2015cites this paper
• Plant polyphenols in the treatment of age-associated diseases: revealing the pleiotropic effects of icariin by network analysis.

  2014cites this paper
• The role of endogenous protein antioxidants in neuronal adaptation to hypobaric hypoxia

  2014cites this paper
• Association between the MMP-921562 C>T polymorphism and the risk of stroke: a meta-analysis

  2014cites this paper
• High matrix metalloproteinase-9 expression induces angiogenesis and basement membrane degradation in stroke-prone spontaneously hypertensive rats after cerebral infarction

  2014influential citation
• Association between the MMP-9−1562 C>T polymorphism and the risk of stroke: a meta-analysis

  2014cites this paper
• Resveratrol inhibits oxygen-glucose deprivation-induced MMP-3 expression and cell apoptosis in primary cortical cells via the NF-κB pathway.

  2014cites this paper
• Hemorrhagic Transformation after Ischemic Stroke in Animals and Humans

  2014cites this paper
• Potential roles of HDAC inhibitors in mitigating ischemia-induced brain damage and facilitating endogenous regeneration and recovery.

  2013cites this paper
• Hemostasis and Alterations of the Central Nervous System

  2013cites this paper
• Expressions of candidate molecules in the human fallopian tube and chorionic villi of tubal pregnancy exposed to levonorgestrel emergency contraception

  2013cites this paper
• Niaspan Attenuates the Adverse Effects of Bone Marrow Stromal Cell Treatment of Stroke in Type One Diabetic Rats

  2013cites this paper
• The role of platelet-derived interleukin-1 alpha as a driver of neutrophil migration in vivo.

  2012cites this paper
• Bone Marrow Chimeras in the Study of Experimental Stroke

  2012cites this paper
• Microglial Cell Activation is a Source of Metalloproteinase Generation during Hemorrhagic Transformation

  2012cites this paper
• Changes in plasma matrix metalloproteinase-9 levels in patients with acute ischemic stroke.

  2012cites this paper
• Targeting the endocannabinod system to limit myocardial and cerebral ischemic and reperfusion injury.

  2012cites this paper
• Modeling of cerebellar hemorrhage.

  2011cites this paper
• Interrupted reperfusion reduces the activation of NADPH oxidase after cerebral I/R injury.

  2011cites this paper
• Cordycepin protects against cerebral ischemia/reperfusion injury in vivo and in vitro.

  2011cites this paper
• Oxidative Stress in Ischemic Brain Damage: Mechanisms of Cell Death and Potential Molecular Targets for Neuroprotection

  2011cites this paper
• Metalloproteinase and stroke infarct size: role for anti‐inflammatory treatment?

  2010cites this paper
• Increase in activity of neutrophils and proinflammatory mediators in rats following acute and prolonged focal cerebral ischemia and reperfusion.

  2010cites this paper
• Mitochondrial and apoptotic neuronal death signaling pathways in cerebral ischemia.

  2010cites this paper
• Hypoxia/Ischemia Signaling

  2010cites this paper
• Bone marrow-derived cells are the major source of MMP-9 contributing to blood-brain barrier dysfunction and infarct formation after ischemic stroke in mice.

  2009cites this paper
• The expression of matrix metalloproteinase-13 is increased in vessels with blood–brain barrier impairment in a stroke-prone hypertensive model

  2009cites this paper
• Psychoneuroimmunology of stroke.

  2009cites this paper
• CD47 gene knockout protects against transient focal cerebral ischemia in mice.

  2009cites this paper
• Severe Blood–Brain Barrier Disruption and Surrounding Tissue Injury

  2009cites this paper
• Reperfusion injury after stroke: neurovascular proteases and the blood-brain barrier.

  2009cites this paper
• Matrix metalloproteinase-9/gelatinase B is a putative therapeutic target of chronic obstructive pulmonary disease and multiple sclerosis.

  2008cites this paper
• Multiphasic roles for matrix metalloproteinases after stroke.

  2008cites this paper
• Early Release of HMGB-1 from Neurons after the Onset of Brain Ischemia

  2008cites this paper
• After Human Ischemic Stroke and Basal Lamina Type IV Collagen Degradation During Hemorrhagic Transformation Brain Barrier Breakdown − Positive Neutrophil Infiltration Is Associated to Blood − MMP-9

  2008cites this paper
• Multiple expression of matrix metalloproteinases in murine neurocysticercosis: Implications for leukocyte migration through multiple central nervous system barriers.

  2008cites this paper
• EVIDENCE OF INFLAMMATORY CELL INVOLVEMENT IN BRAIN ARTERIOVENOUS MALFORMATIONS

  2008cites this paper
• Deficit of pericapillary oligodendrocytes in the prefrontal cortex in schizophrenia

  2008cites this paper
• MMP-9–Positive Neutrophil Infiltration Is Associated to Blood–Brain Barrier Breakdown and Basal Lamina Type IV Collagen Degradation During Hemorrhagic Transformation After Human Ischemic Stroke

  2008cites this paper
• Dynamic Changes in Vascular Permeability, Cerebral Blood Volume, Vascular Density, and Size after Transient Focal Cerebral Ischemia in Rats: Evaluation with Contrast-Enhanced Magnetic Resonance Imaging

  2008cites this paper
• Cannabinoid CB2 Receptor Activation Decreases Cerebral Infarction in a Mouse Focal Ischemia/Reperfusion Model

  2007cites this paper
• Superoxide Dismutases in Stroke

  2007cites this paper
• Cannabinoid CB(2) receptor activation decreases cerebral infarction in a mouse focal ischemia/reperfusion model.

  2007cites this paper
• Vascular Endothelial Growth Factors C and D Represent Novel Prognostic Markers in Colorectal Carcinoma Using Quantitative Image Analysis

  2007cites this paper
• Immunohistochemical changes in vulnerable rat brain regions after reversible global brain ischaemia

  2007cites this paper
• Matrix Metalloproteinases and Tissue Plasminogen Activator Reperfusion Therapy for Stroke

  2007cites this paper
• Integrated molecular profiling of SOD2 expression in multiple myeloma.

  2007cites this paper
• Systemic Inflammatory Stimulus Potentiates the Acute Phase and CXC Chemokine Responses to Experimental Stroke and Exacerbates Brain Damage via Interleukin-1- and Neutrophil-Dependent Mechanisms

  2007cites this paper
• Stroke biomarkers: Can they help us to guide stroke thrombolysis?

  2006cites this paper
• Neurotoxicity of reactive aldehydes: the concept of "aldehyde load" as demonstrated by neuroprotection with hydroxylamines.

  2006influential citation
• AUF‐1 mediates inhibition by nitric oxide of lipopolysaccharide‐induced matrix metalloproteinase‐9 expression in cultured astrocytes

  2006cites this paper
• Hyperbaric oxygen therapy reduces neuroinflammation and expression of matrix metalloproteinase‐9 in the rat model of traumatic brain injury

  2006cites this paper
• Matrix Metalloproteinase-2 Plays a Critical Role in the Pathogenesis of White Matter Lesions After Chronic Cerebral Hypoperfusion in Rodents

  2006cites this paper
• Association between tPA therapy and raised early matrix metalloproteinase-9 in acute stroke

  2006cites this paper
• Evaluating therapeutic targets for reperfusion‐related brain hemorrhage

  2006cites this paper
• Inflammation in adult and neonatal stroke.

  2006cites this paper
• Chronic Cerebral Hypoperfusion in Rodents Matrix Metalloproteinase-2 Plays a Critical Role in the Pathogenesis of White Matter

  2006cites this paper
• Matrix Metalloproteinase-9 Degrades Amyloid-β Fibrils in Vitro and Compact Plaques in Situ*

  2006cites this paper
• Psychoneuroimmunology of stroke.

  2006cites this paper
• Neuroprotection by inhibition of matrix metalloproteinases in a mouse model of intracerebral haemorrhage.

  2005cites this paper
• Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia.

  2005cites this paper
• Effect of neutrophil depletion on gelatinase expression, edema formation and hemorrhagic transformation after focal ischemic stroke

  2005cites this paper
• Free radicals as triggers of brain edema formation after stroke.

  2005cites this paper
• Mechanisms of neuronal degeneration after ischemic stroke – Emerging targets for novel therapeutic strategies

  2005cites this paper
• Decomposition and long‐lasting downregulation of extracellular matrix in perineuronal nets induced by focal cerebral ischemia in rats

  2005cites this paper
• Matrix metalloproteinases and free radicals in cerebral ischemia.

  2005cites this paper
• Delta opioid peptide (D-Ala 2, D-Leu 5) enkephalin: linking hibernation and neuroprotection.

  2004cites this paper